scholarly article | Q13442814 |
P2093 | author name string | Yuying Liang | |
Don Ganem | |||
Joshua Hvidding | |||
Jill T. Bechtel | |||
P2860 | cites work | Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 |
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma | Q28284765 | ||
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease | Q29619158 | ||
A viral gene that activates lytic cycle expression of Kaposi’s sarcoma-associated herpesvirus | Q33559699 | ||
Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line | Q33807199 | ||
Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. | Q33817882 | ||
Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures | Q33841987 | ||
Effective human herpesvirus 8 infection of human umbilical vein endothelial cells by cell-mediated transmission | Q33853082 | ||
Spontaneous activation of the lytic cycle in cells infected with a recombinant Kaposi's sarcoma-associated virus | Q33866016 | ||
Functions of alpha3beta1 integrin | Q34026261 | ||
The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission | Q34388952 | ||
Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma | Q35131811 | ||
Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells | Q36366617 | ||
Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice | Q36375588 | ||
A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant | Q39539612 | ||
Limited Transmission of Kaposi’s Sarcoma-Associated Herpesvirus in Cultured Cells | Q39580911 | ||
Persistent Infection of Epstein-Barr Virus-Positive B Lymphocytes by Human Herpesvirus 8 | Q39581248 | ||
Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis | Q39683622 | ||
De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells | Q39748116 | ||
The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions | Q39877021 | ||
Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells | Q39877852 | ||
Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma | Q39881065 | ||
Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. | Q40139467 | ||
Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells | Q40749885 | ||
The restricted cellular host range of human herpesvirus 8. | Q40868542 | ||
Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma | Q41134075 | ||
Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. | Q41198290 | ||
Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture | Q41225141 | ||
Human papilloma virus E6 and E7 proteins support DNA replication of adenoviruses deleted for the E1A and E1B genes | Q45735748 | ||
Induction of tubulogenesis in telomerase-immortalized human microvascular endothelial cells by glioblastoma cells | Q46445999 | ||
Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells | Q71563744 | ||
Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein | Q77760836 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunology | Q101929 |
microbiology | Q7193 | ||
virus latency | Q4115619 | ||
release from viral latency | Q21130028 | ||
P304 | page(s) | 6474-6481 | |
P577 | publication date | 2003-06-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells | |
Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells | |||
P478 | volume | 77 |
Q59358832 | A Kaposi's Sarcoma-Associated Herpesvirus Infection Mechanism Is Independent of Integrins α3β1, αVβ3, and αVβ5 |
Q42624833 | A Unique Herpesviral Transcriptional Program in KSHV-Infected Lymphatic Endothelial Cells Leads to mTORC1 Activation and Rapamycin Sensitivity |
Q36137293 | A dynamic model for induced reactivation of latent virus |
Q30863867 | Aberrant herpesvirus-induced polyadenylation correlates with cellular messenger RNA destruction |
Q34733560 | Abortive Lytic Reactivation of KSHV in CBF1/CSL Deficient Human B Cell Lines |
Q39913167 | Accumulation of LANA at nuclear matrix fraction is important for Kaposi's sarcoma-associated herpesvirus replication in latency |
Q41494543 | Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype |
Q38315444 | Activation of the B cell antigen receptor triggers reactivation of latent Kaposi's sarcoma-associated herpesvirus in B cells. |
Q34627227 | Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells |
Q36098894 | Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance |
Q53687216 | Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds. |
Q42250620 | Association of Kaposi’s sarcoma-associated herpesvirus (KSHV) with bladder cancer in Croatian patients. |
Q33798426 | BALB/c mice immunized with a combination of virus-like particles incorporating Kaposi sarcoma-associated herpesvirus (KSHV) envelope glycoproteins gpK8.1, gB, and gH/gL induced comparable serum neutralizing antibody activity to UV-inactivated KSHV. |
Q36246375 | Binding of cellular export factor REF/Aly by Kaposi's sarcoma-associated herpesvirus (KSHV) ORF57 protein is not required for efficient KSHV lytic replication |
Q35075128 | Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection. |
Q40247245 | Broad target cell selectivity of Kaposi's sarcoma-associated herpesvirus glycoprotein-mediated cell fusion and virion entry |
Q33585365 | CD8+ T cell evasion mandates CD4+ T cell control of chronic gamma-herpesvirus infection |
Q92501285 | Characterization of de novo lytic infection of dermal lymphatic microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus |
Q39673166 | Characterization of entry and infection of monocytic THP-1 cells by Kaposi's sarcoma associated herpesvirus (KSHV): role of heparan sulfate, DC-SIGN, integrins and signaling |
Q59354603 | Chronic intestinal inflammation in mice expressing viral Flip in epithelial cells |
Q35928663 | Cloning and analysis of microRNAs encoded by the primate gamma-herpesvirus rhesus monkey rhadinovirus |
Q89709261 | Comparative analysis of the viral interferon regulatory factors of KSHV for their requisite for virus production and inhibition of the type I interferon pathway |
Q36467678 | Conceptual emergence of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) as an oral herpesvirus |
Q37010247 | Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent declin |
Q38748712 | Construction of a Lytically Replicating Kaposi's Sarcoma-Associated Herpesvirus |
Q34005284 | Coordination of KSHV Latent and Lytic Gene Control by CTCF-Cohesin Mediated Chromosome Conformation |
Q30311978 | De novo infection with rhesus monkey rhadinovirus leads to the accumulation of multiple intranuclear capsid species during lytic replication but favors the release of genome-containing virions |
Q36668535 | Development of Whole-Virus Multiplex Luminex-Based Serological Assays for Diagnosis of Infections with Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 Homologs in Macaques |
Q41810495 | Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding. |
Q42931199 | ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection |
Q37634746 | Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells |
Q42131073 | Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent |
Q37547223 | Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus |
Q40384607 | Envelope glycoprotein gB of Kaposi's sarcoma-associated herpesvirus is essential for egress from infected cells |
Q27670647 | Enzyme Inhibition by Allosteric Capture of an Inactive Conformation |
Q92225761 | EphA7 Functions as Receptor on BJAB Cells for Cell-to-Cell Transmission of the Kaposi's Sarcoma-Associated Herpesvirus and for Cell-Free Infection by the Related Rhesus Monkey Rhadinovirus |
Q30248457 | Epidemiology of Kaposi's sarcoma-associated herpesvirus in Asia: Challenges and opportunities |
Q34124015 | Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells |
Q35090908 | Expanding the role of Drosha to the regulation of viral gene expression |
Q59350825 | Experimental co-transmission of Simian Immunodeficiency Virus (SIV) and the macaque homologs of the Kaposi Sarcoma-Associated Herpesvirus (KSHV) and Epstein-Barr Virus (EBV) |
Q36607885 | Exploitation of Cellular Cytoskeletons and Signaling Pathways for Cell Entry by Kaposi's Sarcoma-Associated Herpesvirus and the Closely Related Rhesus Rhadinovirus |
Q43181946 | Focal adhesion kinase is critical for entry of Kaposi's sarcoma-associated herpesvirus into target cells |
Q41924146 | Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication |
Q39573744 | Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: Maintenance of tight latency with efficient reactivation upon induction |
Q90434397 | Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation |
Q35718741 | Genotypic profile of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) in urine |
Q40301190 | Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication |
Q90646331 | Glycoprotein K8.1A of Kaposi's Sarcoma-Associated Herpesvirus Is a Critical B Cell Tropism Determinant Independent of Its Heparan Sulfate Binding Activity |
Q38338235 | Highly selective escape from KSHV-mediated host mRNA shutoff and its implications for viral pathogenesis |
Q31156919 | Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus |
Q37333940 | Host shutoff is a conserved phenotype of gammaherpesvirus infection and is orchestrated exclusively from the cytoplasm |
Q33295395 | Host transcript accumulation during lytic KSHV infection reveals several classes of host responses |
Q92295697 | How Kaposi's sarcoma-associated herpesvirus stably transforms peripheral B cells towards lymphomagenesis |
Q80212464 | Immune evasion by Kaposi's sarcoma-associated herpesvirus |
Q35139425 | Importin alpha-mediated nuclear import of cytoplasmic poly(A) binding protein occurs as a direct consequence of cytoplasmic mRNA depletion |
Q39226249 | In vivo and in vitro evidence for an association between the route-specific transmission of HHV-8 and the virus genotype |
Q40364647 | Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. |
Q35383336 | Infection of Lymphoblastoid Cell Lines by Kaposi's Sarcoma-Associated Herpesvirus: Critical Role of Cell-Associated Virus |
Q34602160 | Infection of dendritic cells by a gamma2-herpesvirus induces functional modulation |
Q42710003 | Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells |
Q54217632 | Inhibition of Tip60 Reduces Lytic and Latent Gene Expression of Kaposi's Sarcoma-Associated Herpes Virus (KSHV) and Proliferation of KSHV-Infected Tumor Cells |
Q40045381 | Inhibition of the lytic cycle of Kaposi's sarcoma-associated herpesvirus by cohesin factors following de novo infection |
Q24301712 | Integrin alphaVbeta3 Binds to the RGD motif of glycoprotein B of Kaposi's sarcoma-associated herpesvirus and functions as an RGD-dependent entry receptor |
Q41886930 | Interaction of Adenovirus E1A with the HHV8 Promoter of Latent Genes: E1A Proteins are Able to Activate the HHV-8 LANAp in MV3 Reporter Cells |
Q38262354 | Interaction of KSHV with host cell surface receptors and cell entry |
Q36954898 | Investigation of the susceptibility of human cell lines to bovine herpesvirus 4 infection: demonstration that human cells can support a nonpermissive persistent infection which protects them against tumor necrosis factor alpha-induced apoptosis. |
Q38186778 | Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence? |
Q50176821 | Isolation, characterization and prevalence of a novel Gammaherpesvirus in Eptesicus fuscus, the North American big brown bat. |
Q28072153 | KSHV Entry and Trafficking in Target Cells-Hijacking of Cell Signal Pathways, Actin and Membrane Dynamics |
Q37986049 | KSHV Rta Promoter Specification and Viral Reactivation |
Q33761091 | KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine |
Q37638617 | KSHV cell attachment sites revealed by ultra sensitive tyramide signal amplification (TSA) localize to membrane microdomains that are up-regulated on mitotic cells |
Q26742030 | KSHV-Mediated Angiogenesis in Tumor Progression |
Q40303480 | KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo |
Q92381594 | Kaposi Sarcoma-Associated Herpesvirus Glycoprotein H Is Indispensable for Infection of Epithelial, Endothelial, and Fibroblast Cell Types |
Q94012444 | Kaposi sarcoma |
Q28540116 | Kaposi sarcoma herpes virus latency associated nuclear antigen protein release the G2/M cell cycle blocks by modulating ATM/ATR mediated checkpoint pathway |
Q92376588 | Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Interferes with mTORC1 Regulation of Autophagy and Viral Protein Synthesis |
Q39335582 | Kaposi's Sarcoma-Associated Herpesvirus ORF54/dUTPase Downregulates a Ligand for the NK Activating Receptor NKp44 |
Q47606321 | Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology |
Q34059252 | Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication |
Q35139294 | Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest |
Q34261905 | Kaposi's sarcoma-associated herpesvirus ORF18 and ORF30 are essential for late gene expression during lytic replication |
Q33743857 | Kaposi's sarcoma-associated herpesvirus ORF45 mediates transcriptional activation of the HIV-1 long terminal repeat via RSK2. |
Q35183996 | Kaposi's sarcoma-associated herpesvirus ORF6 gene is essential in viral lytic replication |
Q40721382 | Kaposi's sarcoma-associated herpesvirus modulates microtubule dynamics via RhoA-GTP-diaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to the nucleus |
Q39892759 | Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis |
Q42733497 | Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells |
Q34045753 | Kaposi's sarcoma-associated herpesvirus virion-induced transcription activation of the ORF50 immediate-early promoter |
Q36154559 | Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects |
Q39654515 | Kaposi’s Sarcoma Associated Herpesvirus Entry into Target Cells |
Q59355341 | LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells |
Q39931204 | Lack of heparan sulfate expression in B-cell lines: implications for Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 infections |
Q34102739 | Latent KSHV Infection of Endothelial Cells Induces Integrin Beta3 to Activate Angiogenic Phenotypes |
Q38735021 | Latent Kaposi's sarcoma-associated herpesvirus infection in bladder cancer cells promotes drug resistance by reducing reactive oxygen species |
Q35139228 | Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors |
Q41788529 | Lipid rafts of primary endothelial cells are essential for Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-induced phosphatidylinositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear delivery of viral DNA but dis |
Q82216168 | Localization of human herpesvirus type 8 in human sperms by in situ PCR |
Q40287215 | Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo |
Q40578287 | Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover |
Q35168476 | Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling |
Q59349246 | Macaque homologs of Kaposi's sarcoma-associated herpesvirus (KSHV) infect germinal center lymphoid cells, epithelial cells in skin and gastrointestinal tract and gonadal germ cells in naturally infected macaques |
Q40218296 | Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus |
Q90319823 | Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis |
Q33560572 | Molecular biology of KSHV in relation to AIDS-associated oncogenesis |
Q39435120 | Multiple Defects, Including Premature Apoptosis, Prevent Kaposi's Sarcoma-Associated Herpesvirus Replication in Murine Cells |
Q34578041 | Noncoding RNPs of viral origin |
Q34190177 | Nuclear import of cytoplasmic poly(A) binding protein restricts gene expression via hyperadenylation and nuclear retention of mRNA. |
Q36523994 | ORF33 and ORF38 of Kaposi's Sarcoma-Associated Herpesvirus Interact and Are Required for Optimal Production of Infectious Progeny Viruses |
Q40066566 | ORF73 LANA homologs of RRV and MneRV2 contain an extended RGG/RG-rich nuclear and nucleolar localization signal that interacts directly with importin β1 for non-classical nuclear import |
Q30611167 | PRICE: Software for the Targeted Assembly of Components of (Meta) Genomic Sequence Data |
Q30423529 | Phosphorylation of Eukaryotic Translation Initiation Factor 4B (EIF4B) by Open Reading Frame 45/p90 Ribosomal S6 Kinase (ORF45/RSK) Signaling Axis Facilitates Protein Translation during Kaposi Sarcoma-associated Herpesvirus (KSHV) Lytic Replication |
Q36402817 | Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency |
Q40170202 | Predictors of seropositivity for human herpesvirus type 8 in patients with mild cirrhosis |
Q39271443 | Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas |
Q36546999 | Professional antigen presenting cells in human herpesvirus 8 infection |
Q37727998 | Quantitative Analysis of the KSHV Transcriptome Following Primary Infection of Blood and Lymphatic Endothelial Cells |
Q60952467 | Quantitative RNAseq analysis of Ugandan KS tumors reveals KSHV gene expression dominated by transcription from the LTd downstream latency promoter |
Q42931216 | RNAs in the virion of Kaposi's sarcoma-associated herpesvirus. |
Q38449592 | Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis |
Q39321282 | RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in a Src-dependent manner |
Q92586530 | STING is dispensable during KSHV infection of primary endothelial cells |
Q33314506 | Selection of mutant CHO clones resistant to murine gammaherpesvirus 68 infection |
Q35124429 | Structure and function of latency-associated nuclear antigen |
Q40260079 | Suppression of lytic replication of Kaposi's sarcoma-associated herpesvirus by autophagy during initial infection in NIH 3T3 fibroblasts |
Q30311122 | Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus |
Q35071118 | The KSHV viral interleukin-6 is not essential for latency or lytic replication in BJAB cells |
Q38745798 | The Kaposi's-sarcoma-associated herpesvirus orf35 gene product is required for efficient lytic virus reactivation |
Q34130213 | The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation |
Q92156491 | The Zebrafish Xenograft Platform-A Novel Tool for Modeling KSHV-Associated Diseases |
Q28267511 | The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus |
Q33598569 | The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. |
Q40416504 | The exonuclease and host shutoff functions of the SOX protein of Kaposi's sarcoma-associated herpesvirus are genetically separable |
Q31162657 | The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response |
Q34391203 | The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma |
Q34046103 | The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes. |
Q40231168 | The porcine lymphotropic herpesvirus 1 encodes functional regulators of gene expression |
Q35111065 | Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells |
Q40409705 | Use of a BJAB-derived cell line for isolation of human herpesvirus 8 |
Q40537413 | Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression |
Q34039189 | Viral latency and its regulation: lessons from the gamma-herpesviruses |
Q37092875 | Wild-type Kaposi's sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells |
Search more.